150 related articles for article (PubMed ID: 8623331)
1. Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts.
Rehman A; Tu Y; Flye MW
Transplant Proc; 1996 Apr; 28(2):660-1. PubMed ID: 8623331
[No Abstract] [Full Text] [Related]
2. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
Tu Y; Rehman A; Flye MW
Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
[No Abstract] [Full Text] [Related]
3. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
[TBL] [Abstract][Full Text] [Related]
4. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
[No Abstract] [Full Text] [Related]
5. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
[No Abstract] [Full Text] [Related]
6. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
Chen Z; Cobbold S; Waldmann H; Metcalfe S
Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
[No Abstract] [Full Text] [Related]
7. Inhibitory effect of the complement receptor-specific monoclonal antibody on the induced antibody response and the role of CD4+ and CD8+ T-cells in the rat to mouse xenotransplantation.
Matsumiya G; Shirakura R; Miyagawa S; Nakata S; Nakano S; Kinoshita T; Matsuda H
Transplant Proc; 1993 Feb; 25(1 Pt 1):402-4. PubMed ID: 8438354
[No Abstract] [Full Text] [Related]
8. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
Steinbrüchel DA; Lillevang ST; Nielsen B; Kemp E
Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
[No Abstract] [Full Text] [Related]
9. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
[TBL] [Abstract][Full Text] [Related]
10. The effect of combined treatment with total lymphoid irradiation, cyclosporin A, and anti-CD4 monoclonal antibodies in a hamster-to-rat heart transplantation model.
Steinbrüchel DA; Madsen HH; Nielsen B; Kemp E; Larsen S; Koch C
Transplant Proc; 1991 Feb; 23(1 Pt 1):579-80. PubMed ID: 1990614
[No Abstract] [Full Text] [Related]
11. Review of CTLA4Ig use for allograft immunosuppression.
Lin H; Wei RQ; Gordon D; Linsley P; Turka LA; Bolling SF
Transplant Proc; 1994 Dec; 26(6):3200-1. PubMed ID: 7998114
[No Abstract] [Full Text] [Related]
12. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
Baliga P; Chavin KD; Qin L; Woodward J; Lin J; Linsley PS; Bromberg JS
Transplantation; 1994 Nov; 58(10):1082-90. PubMed ID: 7526493
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats.
Yin DP; Sankary HN; Chong AS; Blinder L; Ma LL; Williams JW
Transplantation; 1997 Jul; 64(2):317-21. PubMed ID: 9256194
[TBL] [Abstract][Full Text] [Related]
14. Reversal of CTLA4Ig-mediated tolerance to cardiac allografts by exogenous interleukin-2.
Arima T; Rehman A; Flye MW
Transplant Proc; 1997; 29(1-2):1305-6. PubMed ID: 9123318
[No Abstract] [Full Text] [Related]
15. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
[No Abstract] [Full Text] [Related]
16. CTLA4-Ig prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice.
Weber CJ; Hagler MK; Chryssochoos JT; Larsen CP; Pearson TC; Jensen P; Kapp JA; Linsley PS
Transplant Proc; 1996 Apr; 28(2):821-3. PubMed ID: 8623418
[No Abstract] [Full Text] [Related]
17. CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
Sablinski T; Hancock WW; Schmidbauer G; Milford EL; Kupiec-Weglinski JW
Transplant Proc; 1992 Apr; 24(2):528-30. PubMed ID: 1566417
[No Abstract] [Full Text] [Related]
18. Prolongation of cardiac graft survival with anti-CD4Ig plus hCTLA4Ig in primates.
Krieger NR; Yuh D; McIntyre WB; Flavin TF; Yin D; Robbins R; Fathman CG
J Surg Res; 1998 May; 76(2):174-8. PubMed ID: 9698519
[TBL] [Abstract][Full Text] [Related]
19. Combined use of RS61443 with CD4 and CD8 MAbs to generate tolerance to skin xenografts from rat to mouse.
Chen Z; Cobbold S; Waldmann H; Metcalfe S
Transplant Proc; 1994 Aug; 26(4):2433-4. PubMed ID: 8066798
[No Abstract] [Full Text] [Related]
20. Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival.
Wee S; Kawai T; Knowles R; Colvin R; Cosimi AB
Transplant Proc; 1993 Feb; 25(1 Pt 1):794-5. PubMed ID: 8438484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
